Notices
The Federal Supply Schedule received questions related to the recently upgraded option to include a "US Made" designation for FSS products. Please select this link to review a list of US Made designation Frequently asked Question and Answers. Download the full Q n A.
The Federal Supply Schedule received several questions following the release of the March 2025 Mass Modification that was directed by Executive Order 14173, Ending Illegal Discrimination and Restoring Merit-Based Opportunity. Please review the Questions and Answers below to clarify issues. Download the full Q n A.
Federal Supply Schedule (FSS) contract holder, VA ordering facilities have contacted FSS and requested that we pursue 97 highly purchased items to be added to the FSS. Product addition modifications for Trades Agreement Act (TAA) compliant versions of these items are encouraged. Please follow the normal Product Request for Modification process to submit any new TAA compliant items.
- Abacavir SO4 600mg/Lamivudine 300mg Tab
- Acamprosate
- Acamprosate CA 333mg EC Tab
- Acamprosate CA 333MG TAB
- Adapalene 0.1% Gel — Pharmaceutical
- Alyacen 1/35 TAB,28
- Amitriptyline HCL 50MG tablet
- Amlodipine 5mg/Benazepril 20mg Cap
- Amlodipine 5mg/Benazepril 40mg Cap
- Amlodipine 10mg/Benazepril 20mg Cap
- APAP 325MG/Butalbital 50MG/CAFN 40MG TAB
- Artificial Saliva (Biotene Mouth) Spray
- Artificial Saliva Oral Spray
- Azathioprine 50mg tab; Amlodipine 5mg/Benazepril 10mg Cap
- Bag Leg Conveen #5170
- Barrier Brava Strips C#120700
- Breast Milk Storage Bag
- Budesonide 0.5MG/2ML INH SUSP 2ML
- Camphor-Menthor-Methyl Salicylate Large Patch
- Camphor/Menthol/Methyl Salicylate Patch
- Camphor Menthol Pain Patch
- Cath Set, Intermit 14FR APOGEE H#B14FB
- Cefpodoxime Tablets
- Cetirizine HCL 5MG TAB
- Clamco Film Reel Holders
- Clindamycin 1% Topical Solution Pharmaceutical
- Clindamycin P04 1% TOP SWAB
- Clindamycin Topical Solution
- Clomiphene Citrate 50mg Tab
- Clomiphene Citrate Pharmaceutical
- Clomiphene Citrate tablets
- Clonazepam .5MG
- Clonazepam 1MG
- Clonazepam 2MG
- Clonazepam 5MG
- Clonazepam 10MG
- Contour Next (Glucose) Test Strip 50CT
- Contour Next (Glucose) Test Strip 100CT
- Darifenacin 7.5mg SA Tab
- Diclofenac NA 25MG EC TAB
- Eyelid Cleanser, Eye Scrub Pad
- Eyelid Cleanser Compliance Kit
- Fenofibrate 145MG TAB
- Galantamine Hydrobromide 8MG SA CAP
- Galantamine Hydrobromide 8mg Tab
- Galantamine Hydrobromide 12MG TAB
- Galantamine Hydrobromide 16MG SA CAP
- Glimepiride 4MG
- Glyburide 5mg/Metformin
- HCTZ 12.5mg/Valsartan 80mg Tab
- Irbesartan 300MG
- Lancet, Onetouch Delica Plus 33G
- Lansoprazole 15MG SA Disintegrating TAB
- Lansoprazole 30MG SA Disintegrating TAB
- Lansoprazole 30MG SA Disintegrating TAB
- Leg Bag Combination H#9349 LATEX FREE
- Magnesium Oxide 140 MG Capsule
- Menthol/M-Salicylate 16-30% Top Cream 85GM
- Metformin HCL 500MG 24HR SA TAB
- Metformin HCL 750MG 24HR SA TAB
- Mineral Oil Enema
- Mineral Oil, Light/Mineral OIL OPH SOLN
- Minoxidil 5% TOP SOLN
- Moisturizer VAG GEL (EQV-REPLENS)
- Moisturizing Lotion 240 & 480
- Naphozoline HCL 0.012% POH SOLN
- Nephro-Vite RX TAB
- Nevirapine 200MG tab
- One Touch Ultra (Glucose) Test Strip 100CT
- One Touch Ultra (Glucose) Test Strip 50CT
- OneTouch Ultra Glucose Test Strips
- Ostomy Venting System (OSTO-EZ-VENT)
- PEG-400 0.4%/PROP GLY 0.3% Eye Drops UD
- Pentetate Calcium Trisodium and Pentetate Zinc Trisodium — Pharmaceuticals
- Permethrin 1% TOP Liquid
- Petrolatum (White) OINT 30GM
- Polyvinyl Alcohol 1.4% Lubricating Eye Drops
- Reservoir, T:SLIM 3ML
- Reservoir, T:SLIM W/T:LOCK,3ML
- Reservoir T:SLIM X2 W/T:LOCK 3ML
- Risperidone 0.5MG tab
- Risperidone 4MG
- Salicyclic Acid 6% TOP GEL
- Set Infusion Autosoft XC TANDEM #1001680
- Set, Infusion Autosoft XC TANDEM #1001681
- Set, Infusion Minimed #MMT-381A
- Sodium Chloride 2% OPH SOLN
- Sumatriptan 6MG/0.5ML INJ Syringe 0.5ML
- Syringe, Feeding ENFIT 60ML
- Tamsulosin — Pharmaceutical
- Timolol Maleate .5% OPH Gel
- Tobramycin Ophthalmic Solution 0.3% 5mL — Pharmaceutical
- Verapamil HCL
- XYLITOL ORAL DISC
- Zolmitriptan 5MG DISINTEGR TAB PKG 3
- Zolpidem Tartrate 6.25MG SA TAB
- Zolpidem Tartrate 12.5MG SA TAB
Per our first notification in March, you were informed that VA FSS will be transitioning the sales reporting and IFF remittance process from the legacy VA Sales Reporting System to GSA’s Federal Acquisition Service (FAS) FAS Sales Reporting Portal (SRP) by the end of CY23.
As part of the upcoming transition, and to align our practices with GSA, we will be shortening the deadline for reporting sales outlined in clause 552.238-80 Industrial Funding Fee and Sales Reporting from 60 to 30 days. Currently VA FSS uses a tailored version of this clause in which we lengthened the reporting time period to 60 days from 30 days (standard clause version).
As this may require adjustments to your internal business operating practices, this advance notice is provided for you to begin preparations for transitioning to the shorter reporting period. The new clause language will be issued via mass modification in late CY23 and take effect on January 1, 2024, coinciding with the transition to the FAS SRP system. You do not have to wait for the new clause language to transition and begin reporting within 30 days after the close of the quarter.
Recommended Action: Please assess the implications of this change and begin preparation to fundamentally change or tweak your internal processes so that you can comfortably achieve Sales report filing and IFF remittance for Quarter 1 of FY 2024 and all subsequent quarters within 30 days after the close of the quarter.